By registering at this site, you certify that you are a healthcare professional licensed in the United States or its territories and are indicating that you wish to receive information about VENCLEXTA (venetoclax tablets) and related disease education. Abbvie's and Genentech's intent is to only provide information to healthcare professionals licensed in the United States or its territories who would likely be treating patients within the FDA-approved indications for this product.

*Required field
  • Clinical Coordinator
  • Clinical Nurse Specialist
  • Homecare Nurse
  • Nurse
  • Nurse Practitioner
  • Pharmacist
  • Physician
  • Physician Assistant
  • Resident/Fellow
  • Other
  • Hematology/Oncology
  • Medical Oncology
  • Radiation Oncology
  • Surgical Oncology
  • Other

By submitting this form, you agree to allow AbbVie Inc. ("AbbVie") and Genentech, Inc. ("Genentech") and their agents to collect the information provided and to be contacted directly by an AbbVie or Genentech sales representative. Your information will not be used for any other purpose than for a representative to respond to your information request, or for us to send you other VENCLEXTA updates if you have registered to receive them.

AbbVie and Genentech will not sell, rent, or otherwise distribute your name and any personally identifiable information outside of AbbVie and Genentech and their agents. AbbVie and Genentech will only use your information in accordance with their Privacy Policy.


You have been added to our contact list and will receive important updates about VENCLEXTA (venetoclax) and related disease education.